🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the weight loss effect of lorcaserin...
Status
Completed
Location
Arena Pharmaceuticals, Inc.
Start Date
2007-12
Trial ID
NCT00603291
Treatments Being Tested
Purpose: The purpose of this study is to test new pharmacologic strategies ...
Status
Terminated
Location
Augusta University
Start Date
2016-09
Trial ID
NCT02796144
Treatments Being Tested
The purpose of this study is to assess the safety and weight loss effect of...
Status
Terminated
Location
Bengbu Medical College First Affiliated Hospital
Start Date
2019-09-17
Trial ID
NCT03720574
Treatments Being Tested
The purpose of this study is to assess the weight loss effect of lorcaserin...
Status
Completed
Location
Arena Pharmaceuticals, Inc.
Start Date
2006-11
Trial ID
NCT00395135
Treatments Being Tested
In smokers who are motivated to stop smoking, treatment with lorcaserin com...
Status
Completed
Location
Pharmacology Research Institute
Start Date
2014-03
Trial ID
NCT02044874
Treatments Being Tested
This study proposes to recruit patients with Opioid Use Disorder (OUD) seek...
Status
Completed
Location
Substance Treatment and Research Service (STARS), Columbia University
Start Date
2017-05-25
Trial ID
NCT03169816
Treatments Being Tested
The purpose of this study is to assess the safety and pharmacokinetics of A...
Status
Completed
Location
Multiple Locations
Start Date
2014-07
Trial ID
NCT02192515
The primary purpose of the study is to demonstrate that lorcaserin has supe...
Status
Terminated
Location
Children's of Alabama / University of Alabama at Birmingham
Start Date
2020-09-23
Trial ID
NCT04572243
Treatments Being Tested
The purpose of this study is to assess the weight loss effect of lorcaserin...
Status
Completed
Location
Arena Pharmaceuticals, Inc.
Start Date
2008-01
Trial ID
NCT00603902
Treatments Being Tested